WebbContact Email [email protected]. Phone Number 603-935-9799. Boston Therapeutics is a pharmaceutical company focused on the development, manufacturing and commercialization of novel compounds to address unmet medical needs in the areas of diabetes and inflammatory diseases. The Company's products are based on the platform … Webb27 feb. 2024 · Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum™, and antisense oligonucleotide (ASO) platform, Solidus™, using our understanding of shared biological targets and circuits in the brain.
Greater Boston Area Therapeutics Companies - CrunchBase
WebbBoston Pharmaceuticals acquires and transforms innovative molecules into differentiated medicines that improve patients’ lives. We have rapidly built a portfolio of high-value … WebbSilicon Therapeutics. 451 D St, Boston, MA 02210, United States. Silicon Therapeutics focused to develop novel medicines for various diseases. This company is a fully … marty wexler
Clade Therapeutics Next-generation stem cell-based medicines
Webb10 mars 2024 · Company summary Overview Nanomix (formerly Boston Therapeutics) is a pharmaceutical company focused on the development, manufacturing and … Webb3 sep. 2024 · BOSTON & CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Sep. 3, 2024-- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that the company has entered into a definitive agreement under which Vertex will acquire Semma Therapeutics, a privately held biotechnology company pioneering the use of stem cell-derived human … WebbMonte Rosa’s MGDs are rationally designed drug-like small molecules that create complementary surfaces between two proteins. We use this novel approach to degrade therapeutically relevant protein targets, including those previously considered undruggable. Learn how we are integrating artificial intelligence, chemistry, and biology to design ... hunter chilled pty ltd